Hledání článků
Filtry
Luan FL, Stuckey LJ, Park JM, Kaul D, Cibrik D, Ojo A. Six‑month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus infection. J Am Soc Nephrol 2009;20:2449–2458.
RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. Intensity of continuous renal‑replacement therapy in critically ill patients. N Engl J Med 2009;361:1627–1638.
Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445–2452.
Marcelli D, Marelli C, Richards N. Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant 2009;12:3566–3572.
Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, Hogan MC. Renal involvement in primary Sjögren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol 2009;4:1423–1431.
Stel VS, Dekker FW, Ansell D, et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transpl 2009;24:3175–3182.
The ASTRAL Investigators. Revascularization versus medical therapy of renal‑artery stenosis. N Engl J Med 2009;361:1953–1962.
Shlipak MG, Katz R, Kestenbaum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 2009, doi:10.1681/ASN.2009050546.
Navaro‑Gonzalez J, Mora‑Fernandez C, Muros M, Herrera H, Garcia J. Mineral metabolism and inflammation in chronic kidney disease patients. Clin J Am Soc Nephrol 2009;4:1646–1654.
Pfeffer MA, Burdmann AE, Chen C‑Y, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009;361: 2019–2032.
Piccoli GB, Conijn A, Consiglio V, Vasario E, Attini R, Deagostini MC, Bontempo S, Todros T. Pregnancy in dialysis patients: is the evidence strong enough to lead us to change our counseling policy? Clin J Am Soc Nephrol 2010;5:62‑71. 2009;4:1974–1979.
Fabris A, Bernich P, Abaterusso C, et al. Bone disease in medullary sponge kidney and effect of potassium citrate treatment. Clin J Am Soc Nephrol 2009;4:1974–1979.
Joannidis M, Druml W, Forni LG, Groeneveld AB, Honore P, Oudemans‑van Straaten HM, Ronco C, Schetz MR, Woittiez AJ. Prevention of acute kidney injury and protection of renal function in the intensive care unit: Expert opinion of the working group for nephrology, ESICM. Intensive Care Med 2010. Epub ahead of print.
Mann JFE, Green D, Jamerson K, et al. Avosentan for overt diabetic nephropathy. J Am Soc Nephrol 2010;21:527–535.